RT
The startup has developed a biotechnology platform that utilizes precision gene editing techniques to create targeted gene therapies for severe and life-threatening diseases. This platform enables healthcare providers to improve patient outcomes by delivering tailored treatments for various genetic disorders.
Updated 2 months ago
Funding
$5.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
HCFunding rounds are not available yet.
Founders
Product
Features
- The startup has developed a biotechnology platform that utilizes precision gene editing techniques to create targeted gene therapies for severe and life-threatening diseases. This platform enables healthcare providers to improve patient outcomes by delivering tailored treatments for various genetic disorders.